We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
1726
APA Corp
APA
$12.8B
$1.12M ﹤0.01%
31,050
-40,014
-56% -$1.61M
INZY
1727
DELISTED
Inozyme Pharma
INZY
$1.12M ﹤0.01%
+195,097
New +$516K
CECO icon
1728
Ceco Environmental
CECO
$3.55B
$1.11M ﹤0.01%
79,544
-172,594
-68% -$2.44M
VZ icon
1729
PUT
Verizon
VZ
$201B
$1.11M ﹤0.01%
28,600
+600
+2% +$23.7K
BASE
1730
DELISTED
Couchbase
BASE
$1.11M ﹤0.01%
+79,097
New +$1.17M
GDXJ icon
1731
CALL
VanEck Junior Gold Miners ETF
GDXJ
$6.81B
$1.11M ﹤0.01%
28,100
-227,300
-89% -$8.4M
CTMX icon
1732
CytomX Therapeutics
CTMX
$690M
$1.1M ﹤0.01%
+729,938
New +$1.65M
MDXG icon
1733
MiMedx Group
MDXG
$649M
$1.1M ﹤0.01%
+322,535
New +$1.25M
ABVEW
1734
CALL
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$1.1M ﹤0.01%
107,213
WTRG icon
1735
Essential Utilities
WTRG
$11.5B
$1.09M ﹤0.01%
+24,979
New +$1.13M
ACAQ.WS
1736
CALL
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$1.09M ﹤0.01%
100,000
-131,619
-57% -$13.9K
EWCZ
1737
DELISTED
European Wax Center
EWCZ
$1.09M ﹤0.01%
57,131
-57,622
-50% -$1.01M
CPUH.WS
1738
CALL
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$1.08M ﹤0.01%
105,803
-19,430
-16% -$6.56K
SLQT icon
1739
SelectQuote
SLQT
$125M
$1.07M ﹤0.01%
+495,040
New +$799K
EPAM icon
1740
EPAM Systems
EPAM
$5.56B
$1.07M ﹤0.01%
+3,591
New +$1.16M
TPIC
1741
DELISTED
TPI Composites
TPIC
$1.07M ﹤0.01%
82,078
-10,600
-11% -$135K
CWT icon
1742
California Water Service
CWT
$3.11B
$1.07M ﹤0.01%
+18,395
New +$1.09M
TIL icon
1743
Instil Bio
TIL
$49.2M
$1.07M ﹤0.01%
80,793
IGF icon
1744
iShares Global Infrastructure ETF
IGF
$10.9B
$1.07M ﹤0.01%
22,334
+15,434
+224% +$730K
ROAD icon
1745
Construction Partners
ROAD
$5.8B
$1.07M ﹤0.01%
+39,544
New +$1.08M
IMKTA icon
1746
Ingles Markets
IMKTA
$1.72B
$1.06M ﹤0.01%
12,000
SPWRW
1747
CALL
SunPower Inc Warrants
SPWRW
$952K
$1.06M ﹤0.01%
103,234
HMA
1748
DELISTED
Heartland Media Acquisition Corp.
HMA
$1.06M ﹤0.01%
102,142
PLAOW
1749
CALL
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$1.06M ﹤0.01%
99,999
YEXT icon
1750
Yext
YEXT
$569M
$1.06M ﹤0.01%
+110,174
New +$848K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.